Immuneering Corp
IMRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001790340
No open-market purchases or sales by Immuneering Corp insiders were filed in the last 90 days; 111 institutions reported holding it in 13F filings for Q2 2026, worth $171.6M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Immuneering Corp as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +1 vs. Q4 2022
- Shares held
- 11.8M
- +88.4K (+0.8%) vs. Q4 2022
- Total value
- $114.9M
- +$58.0M (+102.0%) vs. Q4 2022
- New holders
- 6
- 13 more added
- Sold out
- 5
- 12 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $171.6M |
| Q1 2026 | 96 | $154.3M |
| Q4 2025 | 85 | $208.6M |
| Q3 2025 | 69 | $183.3M |
| Q2 2025 | 39 | $12.9M |
| Q1 2025 | 35 | $6.84M |
| Q4 2024 | 42 | $9.32M |
| Q3 2024 | 38 | $10.9M |
| Q2 2024 | 59 | $12.3M |
| Q1 2024 | 51 | $34.3M |
| Q4 2023 | 52 | $118.6M |
| Q3 2023 | 52 | $130.1M |
| Q2 2023 | 49 | $175.9M |
| Q1 2023 | 35 | $114.9M |
| Q4 2022 | 34 | $56.9M |
| Q3 2022 | 32 | $172.5M |
| Q2 2022 | 37 | $65.7M |
| Q1 2022 | 50 | $88.1M |
| Q4 2021 | 37 | $200.1M |
| Q3 2021 | 38 | $316.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Immuneering Corp; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 5 | $0 | 0.00% | −76−93.8% | Reduced |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 5 | $49 | 0.00% | −4,143−99.9% | Reduced |
| Daiwa Securities Group Inc. | 76 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 126 | $1.22K | 0.00% | +2+1.6% | Added |
| Citigroup Inc | 300 | $2.91K | 0.00% | −103−25.6% | Reduced |
| Cary Street Partner Investment Advisory LLC | 301 | $2.92K | 0.00% | +301 | New |
| China Universal Asset Management Co., Ltd. | 358 | $3.48K | 0.00% | +90+33.6% | Added |
| JPMorgan Chase & Co | 1,030 | $10.0K | 0.00% | +70+7.3% | Added |
| Bank of America Corp | 2,392 | $23.2K | 0.00% | +1,861+350.5% | Added |
| UBS Group AG | 2,713 | $26.3K | 0.00% | +2,713 | New |
| Tower Research Capital LLC (TRC) | 2,768 | $27.0K | 0.00% | −3,608−56.6% | Reduced |
| Barclays PLC | 5,217 | $50.7K | 0.00% | −1,541−22.8% | Reduced |
| Y-Intercept (Hong Kong) Ltd | 11,114 | $107.9K | 0.01% | +11,114 | New |
| Man Group plc | – | $118.2K | 0.00% | – | – |
| Goldman Sachs Group Inc | 26,211 | $254.5K | 0.00% | +15,934+155.0% | Added |
| Morgan Stanley | 27,651 | $268.5K | 0.00% | −17,765−39.1% | Reduced |
| Northern Trust Corp | 37,300 | $362.2K | 0.00% | +2,640+7.6% | Added |
| Bridgeway Capital Management, LLC | 39,049 | $379.2K | 0.01% | +4,100+11.7% | Added |
| Jane Street Group, LLC | 46,571 | $452.2K | 0.00% | +46,571 | New |
| CI Private Wealth, LLC | 46,654 | $453.0K | 0.00% | −765−1.6% | Reduced |
| State Street Corp | 53,735 | $521.8K | 0.00% | −300−0.6% | Reduced |
| Susquehanna International Group, LLP | 57,949 | $562.7K | 0.00% | +12,949+28.8% | Added |
| Manufacturers Life Insurance Company, The | 82,547 | $801.5K | 0.00% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 86,297 | $838.0K | 0.01% | +86,297 | New |
| Millennium Management LLC | 98,786 | $959.0K | 0.00% | +79,116+402.2% | Added |
| Bank of Montreal | 96,028 | $1.01M | 0.00% | +96,028 | New |
| TD Asset Management Inc | 144,103 | $1.40M | 0.00% | −2,611−1.8% | Reduced |
| Geode Capital Management, LLC | 169,219 | $1.64M | 0.00% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 205,000 | $1.99M | 0.00% | +130,000+173.3% | Added |
| FMR LLC | 402,521 | $3.91M | 0.00% | +249,458+163.0% | Added |
| Vanguard Group Inc | 875,968 | $8.51M | 0.00% | +38,289+4.6% | Added |
| BlackRock Inc. | 1,340,193 | $13.0M | 0.00% | −8,191−0.6% | Reduced |
| Citadel Advisors LLC | 2,104,653 | $20.4M | 0.02% | −36,844−1.7% | Reduced |
| Cormorant Asset Management, LP | 2,386,181 | $23.2M | 1.53% | +100,000+4.4% | Added |
| Price T Rowe Associates Inc | 3,458,368 | $33.6M | 0.01% | −161,192−4.5% | Reduced |
| T. Rowe Price Investment Management, Inc. | 0 | $0 | 0.00% | −458,233−100.0% | Sold out |
| Anson Funds Management LP | 0 | $0 | 0.00% | −32,603−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −23,371−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −19,394−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −58−100.0% | Sold out |